acrabose effect on weight loseing
Phase 2
- Conditions
- overweight.Obesity, unspecified
- Registration Number
- IRCT201011151774N3
- Lead Sponsor
- Kerman medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Inclusion criteria were age equal or more than 18 years, willingness to participate in the study, BMI (weight[kg]/ height[m]2 ) between 25-35, no evidence of cardiovascular disease, diabetes, gastrointestinal disease (IBD, intestinal ulcers, bowel obstruction), liver disease and renal disease, no history of medication for lowering weight, women should not be pregnant or milking. The exclusion criteria were no desire to continue the treatment, development of renal, gastrointestinal and liver disease during treatment and beginning to utilize antihypertensive drugs such as ß blocker and thiazides.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BMI. Timepoint: monthly. Method of measurement: meter and weighting scale.
- Secondary Outcome Measures
Name Time Method Fbs, TG, Cholestrol. Timepoint: every three mounth. Method of measurement: lab test.